Search
Dicloxacillin
go.drugbank.com/drugs/DB00485ApprovedInvestigationalVet approvedOne of the penicillins which is resistant to penicillinase.
Synonyms: (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidCategories: Cytochrome P-450 CYP3A Inducers, Heterocyclic Compounds, 2-RingMorning Sickness
go.drugbank.com/conditions/DBCOND0060154Drugs: DimenhydrinateSynonyms: Vomiting in pregnancy (& [excess] or [hyperemesis gravidarum] or [morning sickness])Glycopyrronium
go.drugbank.com/drugs/DB00986ApprovedInvestigationalVet approved[L33105] Glycopyrronium is commonly prescribed as a first line treatment for a wide variety indications and is considered to have a wider therapeutic window than [tiotropium]. … [A233535,A233540] Early research into glycopyrronium use was for its indication as an adjunct therapy in the treatment of peptic ulcers.
Mixtures: TRİMBOW 87/5/9 MCG AEROSOL İNHALASYON ÇÖZELTİSİ, 120 DOZ, TRYDONİS 87 MCG/5 MCG/9 MCG AEROSOL İNHALASYONU, ÇÖZELTİ, 120 DOZCategories: MATE 1 Substrates, Cytochrome P-450 SubstratesApolipoproteins
go.drugbank.com/bio_entities/BE0010065CarrierTargetHumansAppears to be able to transport a variety of ligands in a number of different contexts … Plays a multifaceted role in triglyceride homeostasis (PubMed:18201179, PubMed:22510806).
Polypeptides: Apolipoprotein A-I, Apolipoprotein A-IISynonyms: Lp(a), Apo(a)Disturbance of Attention
go.drugbank.com/conditions/DBCOND0103063Drugs: AniracetamSynonyms: Disturbance in attentionThroat irritation
go.drugbank.com/conditions/DBCOND0010471Drugs: Benzydamine · Cetylpyridinium · Pentoxyverine · Phenol · Pholcodine · Pseudoephedrine +1 moreSynonyms: Irritation in ThroatTrabectedin
go.drugbank.com/drugs/DB05109ApprovedInvestigationalTrabectedin, also referred as ET-743 during its development, is a marine-derived antitumor agent discovered in the Carribean tunicate _Ecteinascidia turbinata_ and now produced synthetically. … Food and Drug Administration (FDA) have approved trabectedin as an orphan drug in soft tissue sarcomas and ovarian cancer.
Categories: Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic IndexProducts: YONDELIS 1 MG IV KONSANTRE INFUZYONLUK COZELTI ICIN TOZ, Trabectedin TEVA 1 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung